Total planned funding: $340,916,329
Clear active filters
John Snow, Inc
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zambia | $122,476,965 |
Uganda | $74,356,144 |
Tanzania | $27,771,435 |
Mozambique | $15,978,309 |
Eswatini | $15,896,438 |
Ethiopia | $13,775,939 |
South Africa | $10,114,710 |
Ghana | $9,474,934 |
Dominican Republic | $9,243,127 |
Botswana | $8,780,073 |
Nigeria | $5,470,630 |
Kenya | $4,550,000 |
West Africa Region | $4,015,397 |
Malawi | $3,670,779 |
Guyana | $2,836,289 |
Caribbean Region | $2,100,000 |
Zimbabwe | $2,008,734 |
Namibia | $1,797,082 |
Haiti | $1,675,000 |
Côte d'Ivoire | $1,050,000 |
Rwanda | $1,034,344 |
Lesotho | $1,000,000 |
Indonesia | $900,000 |
Vietnam | $490,000 |
Central America Region | $450,000 |
Central Asia Region | $0 |
India | $0 |
Organizational Types
Private Contractor | $249,520,898 |
Implementing Agency | $85,050,920 |
NGO | $6,344,511 |
Program Areas
Prevention | $92,058,677 |
Treatment | $74,104,476 |
Governance and Systems | $68,362,497 |
Care | $61,092,573 |
Testing | $24,434,935 |
Budget Codes
HTXS: Treatment: Adult Treatment | $62,005,634 |
OHSS: Health Systems Strengthening | $51,369,828 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $40,988,313 |
HBHC: Care: Adult Care and Support | $33,300,127 |
HVCT: Testing: HIV Testing and Counseling | $24,434,935 |
HVOP: Sexual Prevention: Other Sexual Prevention | $21,974,112 |
HKID: Care: Orphans and Vulnerable Children | $17,887,028 |
HVSI: Strategic Information | $13,798,876 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,926,882 |
HMIN: Biomedical Prevention: Injection Safety | $9,139,164 |
PDTX: Treatment: Pediatric Treatment | $7,798,842 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,030,206 |
HVTB: Care: TB/HIV | $5,419,680 |
PDCS: Care: Pediatric Care and Support | $4,485,738 |
HTXD: Treatment: ARV Drugs | $4,300,000 |
HLAB: Laboratory Infrastructure | $3,193,793 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |